These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 35017716)

  • 21. The great escape? SARS-CoV-2 variants evading neutralizing responses.
    Prévost J; Finzi A
    Cell Host Microbe; 2021 Mar; 29(3):322-324. PubMed ID: 33705702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization.
    Cele S; Jackson L; Khoury DS; Khan K; Moyo-Gwete T; Tegally H; San JE; Cromer D; Scheepers C; Amoako DG; Karim F; Bernstein M; Lustig G; Archary D; Smith M; Ganga Y; Jule Z; Reedoy K; Hwa SH; Giandhari J; Blackburn JM; Gosnell BI; Abdool Karim SS; Hanekom W; ; ; von Gottberg A; Bhiman JN; Lessells RJ; Moosa MS; Davenport MP; de Oliveira T; Moore PL; Sigal A
    Nature; 2022 Feb; 602(7898):654-656. PubMed ID: 35016196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Symptomatic reinfection of SARS-CoV-2 with spike protein variant N440K associated with immune escape.
    Rani PR; Imran M; Lakshmi JV; Jolly B; Jain A; Surekha A; Senthivel V; Chandrasekhar P; Divakar MK; Srinivasulu D; Bhoyar RC; Vanaja PR; Scaria V; Sivasubbu S
    J Med Virol; 2021 Jul; 93(7):4163-4165. PubMed ID: 33818797
    [No Abstract]   [Full Text] [Related]  

  • 24. Structural basis for continued antibody evasion by the SARS-CoV-2 receptor binding domain.
    Nabel KG; Clark SA; Shankar S; Pan J; Clark LE; Yang P; Coscia A; McKay LGA; Varnum HH; Brusic V; Tolan NV; Zhou G; Desjardins M; Turbett SE; Kanjilal S; Sherman AC; Dighe A; LaRocque RC; Ryan ET; Tylek C; Cohen-Solal JF; Darcy AT; Tavella D; Clabbers A; Fan Y; Griffiths A; Correia IR; Seagal J; Baden LR; Charles RC; Abraham J
    Science; 2022 Jan; 375(6578):eabl6251. PubMed ID: 34855508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural Evaluation of the Spike Glycoprotein Variants on SARS-CoV-2 Transmission and Immune Evasion.
    Salleh MZ; Derrick JP; Deris ZZ
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evolution of Immune Evasion and Host Range Expansion by the SARS-CoV-2 B.1.1.529 (Omicron) Variant.
    Ren W; Zhang Y; Rao J; Wang Z; Lan J; Liu K; Zhang X; Hu X; Yang C; Zhong G; Zhang R; Wang X; Shan C; Ding Q
    mBio; 2023 Apr; 14(2):e0041623. PubMed ID: 37010428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insights on the mutational landscape of the SARS-CoV-2 Omicron variant receptor-binding domain.
    Miller NL; Clark T; Raman R; Sasisekharan R
    Cell Rep Med; 2022 Feb; 3(2):100527. PubMed ID: 35233548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fc effector cross-reactivity: A hidden arsenal against SARS-CoV-2's evasive maneuvering.
    Grunst MW; Uchil PD
    Cell Rep Med; 2022 Feb; 3(2):100540. PubMed ID: 35233551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cryo-EM structure of a SARS-CoV-2 omicron spike protein ectodomain.
    Ye G; Liu B; Li F
    Nat Commun; 2022 Mar; 13(1):1214. PubMed ID: 35241675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity.
    Thomson EC; Rosen LE; Shepherd JG; Spreafico R; da Silva Filipe A; Wojcechowskyj JA; Davis C; Piccoli L; Pascall DJ; Dillen J; Lytras S; Czudnochowski N; Shah R; Meury M; Jesudason N; De Marco A; Li K; Bassi J; O'Toole A; Pinto D; Colquhoun RM; Culap K; Jackson B; Zatta F; Rambaut A; Jaconi S; Sreenu VB; Nix J; Zhang I; Jarrett RF; Glass WG; Beltramello M; Nomikou K; Pizzuto M; Tong L; Cameroni E; Croll TI; Johnson N; Di Iulio J; Wickenhagen A; Ceschi A; Harbison AM; Mair D; Ferrari P; Smollett K; Sallusto F; Carmichael S; Garzoni C; Nichols J; Galli M; Hughes J; Riva A; Ho A; Schiuma M; Semple MG; Openshaw PJM; Fadda E; Baillie JK; Chodera JD; ; ; Rihn SJ; Lycett SJ; Virgin HW; Telenti A; Corti D; Robertson DL; Snell G
    Cell; 2021 Mar; 184(5):1171-1187.e20. PubMed ID: 33621484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Omicron: A Heavily Mutated SARS-CoV-2 Variant Exhibits Stronger Binding to ACE2 and Potently Escapes Approved COVID-19 Therapeutic Antibodies.
    Shah M; Woo HG
    Front Immunol; 2021; 12():830527. PubMed ID: 35140714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7.
    Meng B; Kemp SA; Papa G; Datir R; Ferreira IATM; Marelli S; Harvey WT; Lytras S; Mohamed A; Gallo G; Thakur N; Collier DA; Mlcochova P; ; Duncan LM; Carabelli AM; Kenyon JC; Lever AM; De Marco A; Saliba C; Culap K; Cameroni E; Matheson NJ; Piccoli L; Corti D; James LC; Robertson DL; Bailey D; Gupta RK
    Cell Rep; 2021 Jun; 35(13):109292. PubMed ID: 34166617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Substantial Neutralization Escape by SARS-CoV-2 Omicron Variants BQ.1.1 and XBB.1.
    Miller J; Hachmann NP; Collier AY; Lasrado N; Mazurek CR; Patio RC; Powers O; Surve N; Theiler J; Korber B; Barouch DH
    N Engl J Med; 2023 Feb; 388(7):662-664. PubMed ID: 36652339
    [No Abstract]   [Full Text] [Related]  

  • 34. SARS-CoV-2 Omicron: Viral Evolution, Immune Evasion, and Alternative Durable Therapeutic Strategies.
    Guo H; Ha S; Botten JW; Xu K; Zhang N; An Z; Strohl WR; Shiver JW; Fu TM
    Viruses; 2024 Apr; 16(5):. PubMed ID: 38793580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bispecific IgG neutralizes SARS-CoV-2 variants and prevents escape in mice.
    De Gasparo R; Pedotti M; Simonelli L; Nickl P; Muecksch F; Cassaniti I; Percivalle E; Lorenzi JCC; Mazzola F; Magrì D; Michalcikova T; Haviernik J; Honig V; Mrazkova B; Polakova N; Fortova A; Tureckova J; Iatsiuk V; Di Girolamo S; Palus M; Zudova D; Bednar P; Bukova I; Bianchini F; Mehn D; Nencka R; Strakova P; Pavlis O; Rozman J; Gioria S; Sammartino JC; Giardina F; Gaiarsa S; Pan-Hammarström Q; Barnes CO; Bjorkman PJ; Calzolai L; Piralla A; Baldanti F; Nussenzweig MC; Bieniasz PD; Hatziioannou T; Prochazka J; Sedlacek R; Robbiani DF; Ruzek D; Varani L
    Nature; 2021 May; 593(7859):424-428. PubMed ID: 33767445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species.
    Wang R; Zhang Q; Ge J; Ren W; Zhang R; Lan J; Ju B; Su B; Yu F; Chen P; Liao H; Feng Y; Li X; Shi X; Zhang Z; Zhang F; Ding Q; Zhang T; Wang X; Zhang L
    Immunity; 2021 Jul; 54(7):1611-1621.e5. PubMed ID: 34166623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High affinity nanobodies block SARS-CoV-2 spike receptor binding domain interaction with human angiotensin converting enzyme.
    Esparza TJ; Martin NP; Anderson GP; Goldman ER; Brody DL
    Sci Rep; 2020 Dec; 10(1):22370. PubMed ID: 33353972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody escape and cryptic cross-domain stabilization in the SARS-CoV-2 Omicron spike protein.
    Javanmardi K; Segall-Shapiro TH; Chou CW; Boutz DR; Olsen RJ; Xie X; Xia H; Shi PY; Johnson CD; Annapareddy A; Weaver S; Musser JM; Ellington AD; Finkelstein IJ; Gollihar JD
    Cell Host Microbe; 2022 Sep; 30(9):1242-1254.e6. PubMed ID: 35988543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic.
    Hoffmann M; Krüger N; Schulz S; Cossmann A; Rocha C; Kempf A; Nehlmeier I; Graichen L; Moldenhauer AS; Winkler MS; Lier M; Dopfer-Jablonka A; Jäck HM; Behrens GMN; Pöhlmann S
    Cell; 2022 Feb; 185(3):447-456.e11. PubMed ID: 35026151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants.
    Yuan M; Huang D; Lee CD; Wu NC; Jackson AM; Zhu X; Liu H; Peng L; van Gils MJ; Sanders RW; Burton DR; Reincke SM; Prüss H; Kreye J; Nemazee D; Ward AB; Wilson IA
    Science; 2021 Aug; 373(6556):818-823. PubMed ID: 34016740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.